LDLeonie K. Duin

Leonie K. Duin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Leonie K. Duin has a total of 62 co-authors. Here are the top co-authors by number of shared publications:

  • Federica Fontanella

    Department of Obstetrics and Gynecology, University Medical Center Groningen, 9713 GZ Groningen, The Netherlands

    6 shared publications
  • Catherina M. Bilardo

    Department of Obstetrics and Gynecology, University Medical Center Groningen, University of Groningen, Groningen, Netherlands

    4 shared publications
  • C. Willekes

    Department of Obstetrics, Gynecology and Prenatal Diagnosis University Medical Center, Grow School for Oncology and Medical Biology Maastricht The Netherlands

    3 shared publications
  • E. Pajkrt

    Department of Obstetrics and Gynecology, Amsterdam University Medical Center University of Amsterdam Amsterdam The Netherlands

    3 shared publications
  • D. Oepkes

    Department of Obstetrics, Leiden University Medical Center, Leiden, the Netherlands

    2 shared publications
  • Lauret A. M. Brinkman

    Department of Obstetrics and Gynecology, University Medical Center Groningen University of Groningen Groningen The Netherlands

    2 shared publications

Latest Publications

  • Open Access

    Interobserver agreement in prenatal ultrasound assessment of fetal urinary tract dilatation

    by Silvia Spinnato, Lauret A. M. Brinkman, Leonie K. Duin, Valentina Gracchi, Charlotte M. H. H. T. Bootsma-Robroeks, Caterina M. Bilardo, Sanne J. Gordijn, Federica Fontanella

    Background: To assess interobserver agreement in the evaluation of the fetal urinary tract in fetuses with urinary tract dilatation (UTD). Methods: We conducted a retrospective study evaluating interobserver agreement on renal tract features using third-trimester renal ultrasound images of fetuses with UTD. Two fetal medicine specialists and two pediatric nephrologists independently and systematically assessed ultrasound features of the fetal renal parenchyma and urinary bladder, as well as the Society for Fetal Urology (SFU) and the ONEN grading systems. Interobserver variability was analyzed using Cohen’s kappa statistics and intraclass correlation coefficients (ICC). Results: A total of 1639 ultrasound images from 144 fetuses with antenatal UTD were analyzed. Slight to moderate agreement was observed for most renal ultrasound parameters, including cortico-medullary differentiation (κ = 0.28–0.50), renal echogenicity (κ = 0.18–0.45), and cortical cysts (κ = 0.02–0.15). A similar pattern was observed for the subjective assessment of bladder features. In contrast, both the SFU and the ONEN grading system demonstrated moderate to substantial agreement, with ICC values ranging from 0.61 to 0.73 and 0.55 to 0.66, respectively, and kappa values from 0.38 to 0.63 and 0.48 to 0.67. Conclusion: Significant interobserver variability exists in the interpretation of commonly used prenatal ultrasound features for evaluating the fetal urinary tract and predicting postnatal outcomes in UTD. The SFU and the ONEN grading systems improved agreement, supporting the need for standardized ultrasound assessment tools to enhance prenatal counseling and antenatal management in fetuses with UTD.

  • Open Access

    Pop‐off mechanisms in fetal megacystis: extravasation, umbilical cord cyst, ureterocele and megaureter

    by L. A. M. Brinkman, L. K. Duin, P. N. Adama van Scheltema, T. E. Cohen‐Overbeek, E. Pajkrt, M. N. Bekker, C. Willekes, E. J. T. Verweij, C. Bilardo, F. Fontanella

    Objective: To analyze comprehensively the incidence, antenatal ultrasound characteristics and prognostic implications of antenatal pop‐off mechanisms of the fetal urinary system in pregnancies with suspected fetal megacystis.Methods: This was a retrospective multicenter study of pregnancies with suspected fetal megacystis conducted across all academic hospitals in The Netherlands. Three antenatal pop‐off mechanisms were identified: presence of an umbilical cord cyst (UCC), extravasation of urine into the intraperitoneal space (ascites) or perirenal subcapsular (urinoma), and megaureter/ureterocele. Cases that exhibited two different pop‐off mechanisms, underwent vesicoamniotic shunt placement or had unclear information regarding shunt placement were excluded. We compared the antenatal ultrasound characteristics and outcomes among pregnancies with UCC, those with extravasation, those with megaureter/ureterocele and those without a pop‐off mechanism. Logistic regression analysis was used to evaluate the association of pop‐off mechanisms with antenatal characteristics and postnatal outcomes.Results: Among 543 fetuses with suspected megacystis, 76% exhibited no pop‐off mechanism, 7% presented with UCC only, 9% presented with extravasation only, 7% presented with a megaureter/ureterocele only and 1% presented with two pop‐off mechanisms. Following exclusions, 511 cases were included in the analysis. The identification of UCC (n = 39) was associated with early‐onset megacystis (odds ratio (OR), 4.2 (95% CI, 1.9–9.1); P < 0.001), severe megacystis (OR 2.3 (95% CI, 1.1–5.0); P = 0.033), normal amniotic fluid index (AFI) (OR, 3.3 (95% CI, 1.3–8.2); P = 0.011) and additional associated anomaly (OR, 3.3 (95% CI, 1.7–6.4); P < 0.001), and thus with the highest prevalence of complex diagnosis (66%), primarily represented by anorectal malformation. Extravasation (n = 42) was associated with severe megacystis (OR, 2.4 (95% CI, 1.1–5.4); P = 0.030), abnormal AFI (OR, 2.8 (95% CI, 1.2–6.8); P = 0.022), the keyhole sign (OR, 2.5 (95% CI, 1.1–5.8); P = 0.033) and additional associated anomaly (OR, 2.1 (95% CI, 1.1–4.1); P = 0.026). Megaureter/ureterocele (n = 36) was associated with late‐onset megacystis (OR, 4.0 (95% CI, 1.6–9.7); P = 0.003), a thickened bladder wall during pregnancy (OR, 6.6 (95% CI, 1.9–23.1); P = 0.003) and the lowest prevalence of additional associated anomaly (22%).Intrauterine fetal demise was most prevalent in fetuses with UCC (15%), while termination of pregnancy and non‐survivors were most common in cases with extravasation (50% and 17%, respectively). The majority of fetuses with megacystis associated with megaureter/ureterocele were still alive during follow‐up (72%) and the odds of survival were the highest for this group (OR, 2.7 (95% CI, 1.3–5.7); P = 0.010).Conclusions: Antenatal pop‐off mechanisms may alleviate high intraluminal pressure within the fetal urinary tract. Each mechanism leads to a different antenatal clinical picture and outcome, which may explain partially the heterogeneity of outcomes in fetuses with megacystis. Therefore, understanding the implications of these mechanisms and their antenatal characteristics could guide antenatal counseling and management of fetal megacystis. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    Limitations of Semi-Automated Immunomagnetic Separation of HLA-G-Positive Trophoblasts from Papanicolaou Smears for Prenatal Genetic Diagnostics

    by Eddy N. de Boer, Nicole Corsten-Janssen, Elles Wierenga, Theo Bijma, Jurjen T. Knapper, Gerard J. Te Meerman, Gwendolyn T. R. Manten, Nine V. A. M. Knoers, Katelijne Bouman, Leonie K. Duin, et al.

    Background: In prenatal genetic diagnostics, the detection of single-gene defects relies on chorionic villus sampling (CVS) and amniocentesis, which carry a miscarriage risk of 0.2–0.3%. To mitigate this risk, fetal trophoblasts have been isolated from a Papanicolaou smear using Trophoblast Retrieval and Isolation from the Cervix (TRIC). However, this method is labor-intensive and has been shown to be challenging to implement in clinical practice. Here, we describe our experiences in using semi-automated immunomagnetic cell sorting for isolating trophoblasts from clinically obtained Papanicolaou smears during ongoing pregnancies. Methods: Using HLA-G-positive Jeg-3 and HLA-G-negative HeLa cell lines in 10%, 1%, and 0.1% dilutions, we tested and optimized the isolation of HLA-G-positive cells using FACS and semi-automated immunomagnetic cell sorting. We used the latter technique for isolation of HLA-G-positive cells from Papanicolaou smears collected from 26 pregnant women, gestational age between 6 and 20 weeks, who underwent CVS. Results: In four independent dilution series, the mean percentages of Jeg-3 cells went from 7.1% to 53.5%, 0.9% to 32.6%, and 0.4% to 2.6% (7.5, 36, and 6.5-fold enrichment, respectively) using immunomagnetic cell sorting. After sorting of the Papanicolaou smears, HLA-G-positive cells were moderately increased in the positive (14.61 vs. 11.63%) and decreased in the negative fraction (7.87 vs. 11.63%) compared to baseline pre-sorting. However, we could not identify fetal cells using XY-chromosomal FISH in a male sample. Conclusions: Our study supports previous findings that careful sampling of fetal cells from Papanicolaou smears in a clinical context poses significant challenges to cell retrieval.


  • Open Access

    Z‐scores of fetal bladder size for antenatal differential diagnosis between posterior urethral valves and urethral atresia

    by F. Fontanella, H. Groen, L. K. Duin, S. Suresh, C. M. Bilardo

    Objective: To construct reference values for fetal urinary bladder distension in pregnancy and use Z‐scores as a diagnostic tool to differentiate posterior urethral valves (PUV) from urethral atresia (UA).Methods: This was a prospective cross‐sectional study in healthy singleton pregnancies aimed at constructing nomograms of fetal urinary bladder diameter and volume between 15 and 35 weeks' gestation. Z‐scores of longitudinal bladder diameter (LBD) were calculated and validated in a cohort of fetuses with megacystis with ascertained postnatal or postmortem diagnosis, collected from a retrospective, multicenter study. Correlations between anatomopathological findings, based on medical examination of the infant or postmortem examination, and fetal megacystis were established. The accuracy of the Z‐scores was evaluated by receiver‐operating‐characteristics (ROC)‐curve analysis.Results: Nomograms of fetal urinary bladder diameter and volume were produced from three‐dimensional ultrasound volumes in 225 pregnant women between 15 and 35 weeks of gestation. A total of 1238 urinary bladder measurements were obtained. Z‐scores, derived from the fetal nomograms, were calculated in 106 cases with suspected lower urinary tract obstruction (LUTO), including 76 (72%) cases with PUV, 22 (21%) cases with UA, four (4%) cases with urethral stenosis and four (4%) cases with megacystis‐microcolon‐intestinal hypoperistalsis syndrome. Fetuses with PUV showed a significantly lower LBD Z‐score compared to those with UA (3.95 vs 8.83, P < 0.01). On ROC‐curve analysis, we identified 5.2 as the optimal Z‐score cut‐off to differentiate fetuses with PUV from the rest of the study population (area under the curve, 0.84 (95% CI, 0.748–0.936); P < 0.01; sensitivity, 74%; specificity, 86%).Conclusions: Z‐scores of LBD can distinguish reliably fetuses with LUTO caused by PUV from those with other subtypes of LUTO, with an optimal cut‐off of 5.2. This information should be useful for prenatal counseling and management of LUTO. © 2021 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    A prospective study on rapid exome sequencing as a diagnostic test for multiple congenital anomalies on fetal ultrasound

    by Nicole Corsten‐Janssen, Katelijne Bouman, Janouk C. D. Diphoorn, Arjen J. Scheper, Rianne Kinds, Julia el Mecky, Hanna Breet, Joke B. G. M. Verheij, Ron Suijkerbuijk, Leonie K. Duin, et al.

    Objective: Conventional genetic tests (quantitative fluorescent‐PCR [QF‐PCR] and single nucleotide polymorphism‐array) only diagnose ~40% of fetuses showing ultrasound abnormalities. Rapid exome sequencing (rES) may improve this diagnostic yield, but includes challenges such as uncertainties in fetal phenotyping, variant interpretation, incidental unsolicited findings, and rapid turnaround times. In this study, we implemented rES in prenatal care to increase diagnostic yield.Methods: We prospectively studied 55 fetuses. Inclusion criteria were: (a) two or more independent major fetal anomalies, (b) hydrops fetalis or bilateral renal cysts alone, or (c) one major fetal anomaly and a first‐degree relative with the same anomaly. In addition to conventional genetic tests, we performed trio rES analysis using a custom virtual gene panel of ~3850 Online Mendelian Inheritance in Man (OMIM) genes.Results: We established a genetic rES‐based diagnosis in 8 out of 23 fetuses (35%) without QF‐PCR or array abnormalities. Diagnoses included MIRAGE (SAMD9), Zellweger (PEX1), Walker‐Warburg (POMGNT1), Noonan (PTNP11), Kabuki (KMT2D), and CHARGE (CHD7) syndrome and two cases of Osteogenesis Imperfecta type 2 (COL1A1). In six cases, rES diagnosis aided perinatal management. The median turnaround time was 14 (range 8‐20) days.Conclusion: Implementing rES as a routine test in the prenatal setting is challenging but technically feasible, with a promising diagnostic yield and significant clinical relevance.


  • Prediction model of postnatal renal function in fetuses with lower urinary tract obstruction (LUTO)—Development and internal validation

    by Leonie K. Duin, Federica Fontanella, Henk Groen, Phebe N. Adama van Scheltema, Titia E. Cohen‐Overbeek, Eva Pajkrt, Mireille Bekker, Christine Willekes, Caroline J. Bax, Dick Oepkes, et al.

    Objective: To develop a prediction model of postnatal renal function in fetuses with lower urinary tract obstruction (LUTO) based on fetal ultrasound parameters and amniotic fluid volume.Methods: Retrospective nationwide cohort study of fetuses with postnatally confirmed LUTO and known eGFR. Fetuses treated with fetal interventions such as vesico‐amniotic shunting or cystoscopy were excluded. Logistic regression analysis was used to identify prognostic ultrasound variables with respect to renal outcome following multiple imputation of missing data. On the basis of these fetal renal parameters and amniotic fluid volume, a model was developed to predict postnatal renal function in fetuses with LUTO. The main study outcome was an eGFR less than 60 mL/min * 1.73 m2 based on the creatinine nadir during the first year following diagnosis. Model performance was evaluated by receiver operator characteristic (ROC) curve analysis, calibration plots, and bootstrapping.Results: Hundred one fetuses with a confirmed diagnosis of LUTO were included, eGFR less than 60 was observed in 40 (39.6%) of them. Variables predicting an eGFR less than 60 mL/min * 1.73m2 included the following sonographic parameters: hyperechogenicity of the renal cortex and abnormal amniotic fluid volume. The model showed fair discrimination, with an area under the ROC curve of 0.70 (95% confidence interval, 0.59‐0.81, 0.66 after bootstrapping) and was overall well‐calibrated.Conclusion: This study shows that a prediction model incorporating ultrasound parameters such as cortical appearance and abnormal amniotic fluid volume can fairly discriminate an eGFR above or below 60 mL/min * 1.73m2. This clinical information can be used in identifying fetuses eligible for prenatal interventions and improve counseling of parents.


  • Antenatal staging of congenital lower urinary tract obstruction

    by F. Fontanella, P. N. Adama van Scheltema, L. Duin, T. E. Cohen‐Overbeek, E. Pajkrt, M. N. Bekker, C. Willekes, D. Oepkes, C. M. Bilardo

    Objective: To propose a staging system for congenital lower urinary tract obstruction (LUTO) capable of predicting the severity of the condition and its prognosis.Methods: This was a national retrospective study carried out at the eight Academic Hospitals in The Netherlands. We collected prenatal and postnatal data of fetuses at high risk of isolated LUTO that were managed conservatively. Postnatal renal function was assessed by the estimated glomerular filtration rate (eGFR), calculated using the Schwartz formula, considering the length of the infant and the creatinine nadir in the first year after birth. Receiver–operating characteristics (ROC) curve analysis, univariate analysis and multivariate logistic regression analysis with stepwise backward elimination were performed in order to identify the best antenatal predictors of perinatal mortality and postnatal renal function.Results: In total, 261 fetuses suspected of having LUTO and managed conservatively were included in the study. The pregnancy was terminated in 110 cases and perinatal death occurred in 35 cases. Gestational age at appearance of oligohydramnios showed excellent accuracy in predicting the risk of perinatal mortality with an area under the ROC curve of 0.95 (P < 0.001) and an optimal cut‐off at 26 weeks' gestation. Fetuses with normal amniotic fluid (AF) volume at 26 weeks' gestation presented with low risk of poor outcome and were therefore defined as cases with mild LUTO. In fetuses referred before the 26th week of gestation, the urinary bladder volume (BV) was the best unique predictor of perinatal mortality. ROC curve analysis identified a BV of 5.4 cm3 and appearance of oligohydramnios at 20 weeks as the best threshold for predicting an adverse outcome. LUTO cases with a BV ≥ 5.4 cm3 or abnormal AF volume before 20 weeks' gestation were defined as severe and those with BV < 5.4 cm3 and normal AF volume at the 20 weeks' scan were defined as moderate. Risk of perinatal mortality significantly increased according to the stage of severity, from mild to moderate to severe stage, from 9% to 26% to 55%, respectively. Similarly, risk of severely impaired renal function increased from 11% to 31% to 44%, for mild, moderate and severe LUTO, respectively.Conclusions: Gestational age at appearance of oligo‐ or anhydramnios and BV at diagnosis can accurately predict mortality and morbidity in fetuses with LUTO. Our proposed staging system can triage reliably fetuses with LUTO and predict the severity of the condition and its prognosis. Copyright © 2018 ISUOG. Published by John Wiley & Sons Ltd.


  • Open Access

    Fetal megacystis: a lot more than LUTO

    by F. Fontanella, L. Maggio, J. B. G. M. Verheij, L. K. Duin, P. N. Adama Van Scheltema, T. E. Cohen‐Overbeek, E. Pajkrt, M. Bekker, C. Willekes, C. J. Bax, et al.

    Objective: Fetal megacystis presents a challenge in terms of counseling and management because of its varied etiology and evolution. The aim of this study was to present a comprehensive overview of the underlying etiologies and structural anomalies associated with fetal megacystis.Methods: This was a retrospective multicenter study of cases referred to the fetal medicine unit of one of the eight academic hospitals in The Netherlands with a diagnosis of fetal megacystis. For each case, data on and measurements of fetal urinary tract and associated structural anomalies were collected. All available postmortem examinations and postnatal investigations were reviewed in order to establish the final diagnosis. In the first trimester, fetal megacystis was defined as longitudinal bladder diameter (LBD) ≥ 7 mm, and in the second and third trimesters as an enlarged bladder failing to empty during an extended ultrasound examination lasting at least 40 min.Results: Of the 541 pregnancies with fetal megacystis, it was isolated (or solely accompanied by other signs of lower urinary tract obstruction (LUTO)) in 360 (67%) cases and associated with other abnormal ultrasound findings in 181 (33%) cases. The most common associated ultrasound anomaly was an increased nuchal translucency thickness (22%), followed by single umbilical artery (10%) and cardiac defect (10%). A final diagnosis was established in 418 cases, including 222 (53%) cases with isolated LUTO and 60 (14%) infants with normal micturition or minor isolated urological anomalies. In the remaining 136 (33%) cases, concomitant developmental or chromosomal abnormality or genetic syndrome was diagnosed. Overall, 40 chromosomal abnormalities were diagnosed, including trisomy 18 (n = 24), trisomy 21 (n = 5), Turner syndrome (n = 5), trisomy 13 (n = 3) and 22q11 deletion (n = 3). Thirty‐two cases presented with anorectal malformations involving the anus, rectum and urogenital tract. In cases with confirmed urethral and anal atresia, megacystis occurred early in pregnancy and the bladder appeared severely distended (the LBD (in mm) was equal to or greater than twice the gestational age (in weeks)). Fetal macrosomia was detected in six cases and an overgrowth syndrome was detected in four cases, comprising two infants with Beckwith–Wiedemann syndrome and two with Sotos syndrome. Megacystis‐microcolon‐intestinal hypoperistalsis syndrome was diagnosed in five (1%) cases and prenatally suspected only in one case.Conclusions: Although the main cause of fetal megacystis is LUTO, an enlarged fetal bladder can also be present as a concomitant finding of miscellaneous genetic syndromes, developmental disturbances and chromosomal abnormalities. We provide an overview of the structural anomalies and congenital disorders associated with fetal megacystis and propose a practical guide for the differential diagnosis of genetic syndromes and chromosomal and developmental abnormalities in pregnancies presenting with fetal megacystis, focusing on the morphological examination of the fetus. © 2018 The Authors. Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of the International Society of Ultrasound in Obstetrics and Gynecology.


  • Open Access

    OC21.01: Antenatal ultrasound prediction of postnatal renal function in congenital lower urinary tract obstruction

    by F. Fontanella, M. Pace, L. Duin, V. Gracchi, E. Pajkrt, C.M. Bilardo